• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激响应型纳米技术在 RNA 递送中的应用

Stimuli-Responsive Nanotechnology for RNA Delivery.

机构信息

Department of Cardiology, Clinical Trial Center, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, 430071, Wuhan, China.

Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.

出版信息

Adv Sci (Weinh). 2023 Dec;10(36):e2303597. doi: 10.1002/advs.202303597. Epub 2023 Nov 1.

DOI:10.1002/advs.202303597
PMID:37915127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10754096/
Abstract

Ribonucleic acid (RNA) drugs have shown promising therapeutic effects for various diseases in clinical and preclinical studies, owing to their capability to regulate the expression of genes of interest or control protein synthesis. Different strategies, such as chemical modification, ligand conjugation, and nanotechnology, have contributed to the successful clinical translation of RNA medicine, including small interfering RNA (siRNA) for gene silencing and messenger RNA (mRNA) for vaccine development. Among these, nanotechnology can protect RNAs from enzymatic degradation, increase cellular uptake and cytosolic transportation, prolong systemic circulation, and improve tissue/cell targeting. Here, a focused overview of stimuli-responsive nanotechnologies for RNA delivery, which have shown unique benefits in promoting RNA bioactivity and cell/organ selectivity, is provided. Many tissue/cell-specific microenvironmental features, such as pH, enzyme, hypoxia, and redox, are utilized in designing internal stimuli-responsive RNA nanoparticles (NPs). In addition, external stimuli, such as light, magnetic field, and ultrasound, have also been used for controlling RNA release and transportation. This review summarizes a wide range of stimuli-responsive NP systems for RNA delivery, which may facilitate the development of next-generation RNA medicines.

摘要

核糖核酸(RNA)药物在临床和临床前研究中显示出对各种疾病有很有前景的治疗效果,这是因为它们能够调节感兴趣的基因的表达或控制蛋白质的合成。不同的策略,如化学修饰、配体偶联和纳米技术,都有助于 RNA 药物的成功临床转化,包括用于基因沉默的小干扰 RNA(siRNA)和用于疫苗开发的信使 RNA(mRNA)。在这些策略中,纳米技术可以保护 RNA 免受酶降解,增加细胞摄取和细胞质运输,延长系统循环,并提高组织/细胞靶向性。在这里,我们重点介绍了用于 RNA 递送的响应性纳米技术,这些技术在促进 RNA 生物活性和细胞/组织选择性方面具有独特的优势。许多组织/细胞特异性的微环境特征,如 pH 值、酶、缺氧和氧化还原等,都被用于设计内部响应性 RNA 纳米颗粒(NPs)。此外,外部刺激,如光、磁场和超声,也被用于控制 RNA 的释放和运输。本综述总结了广泛的用于 RNA 递送的响应性 NP 系统,这可能有助于开发下一代 RNA 药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/af79bb218c67/ADVS-10-2303597-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/9d3c24677b7f/ADVS-10-2303597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6401be1cd61b/ADVS-10-2303597-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/94d58d295c53/ADVS-10-2303597-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/2b46ce58ca41/ADVS-10-2303597-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6ba4238ca690/ADVS-10-2303597-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/c7f1e776f9ed/ADVS-10-2303597-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6166af0cd0cb/ADVS-10-2303597-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/f56f5fd298ee/ADVS-10-2303597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/edd75cf1ea7f/ADVS-10-2303597-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/4687da653400/ADVS-10-2303597-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/b20dd371396a/ADVS-10-2303597-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/af79bb218c67/ADVS-10-2303597-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/9d3c24677b7f/ADVS-10-2303597-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6401be1cd61b/ADVS-10-2303597-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/94d58d295c53/ADVS-10-2303597-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/2b46ce58ca41/ADVS-10-2303597-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6ba4238ca690/ADVS-10-2303597-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/c7f1e776f9ed/ADVS-10-2303597-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/6166af0cd0cb/ADVS-10-2303597-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/f56f5fd298ee/ADVS-10-2303597-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/edd75cf1ea7f/ADVS-10-2303597-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/4687da653400/ADVS-10-2303597-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/b20dd371396a/ADVS-10-2303597-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e9a/10754096/af79bb218c67/ADVS-10-2303597-g028.jpg

相似文献

1
Stimuli-Responsive Nanotechnology for RNA Delivery.刺激响应型纳米技术在 RNA 递送中的应用
Adv Sci (Weinh). 2023 Dec;10(36):e2303597. doi: 10.1002/advs.202303597. Epub 2023 Nov 1.
2
Stimuli-responsive nanoscale drug delivery systems for cancer therapy.刺激响应型纳米药物递送系统用于癌症治疗。
J Drug Target. 2019 Apr;27(4):423-433. doi: 10.1080/1061186X.2018.1519029. Epub 2019 Jan 24.
3
RNA Nanomedicine: Delivery Strategies and Applications.RNA 纳米医学:递药策略与应用。
AAPS J. 2023 Oct 2;25(6):95. doi: 10.1208/s12248-023-00860-z.
4
Cellular Trafficking of Nanotechnology-Mediated mRNA Delivery.纳米技术介导的mRNA递送的细胞转运
Adv Mater. 2024 Mar;36(13):e2307822. doi: 10.1002/adma.202307822. Epub 2023 Dec 12.
5
Nanosize drug delivery system.纳米尺寸药物递送系统。
Curr Pharm Biotechnol. 2013;14(15):1221. doi: 10.2174/138920101415140804121008.
6
Stimuli-Responsive Nanoparticles for siRNA Delivery.用于 siRNA 递送的刺激响应性纳米颗粒
Curr Pharm Des. 2015;21(29):4131-44. doi: 10.2174/1381612821666150901095349.
7
Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.刺激响应型聚合物前药杂化纳米平台用于多阶段 siRNA 递药和联合癌症治疗。
Nano Lett. 2019 Sep 11;19(9):5967-5974. doi: 10.1021/acs.nanolett.9b01660. Epub 2019 Aug 7.
8
Environment-Responsive Lipid/siRNA Nanoparticles for Cancer Therapy.用于癌症治疗的环境响应性脂质/小干扰RNA纳米颗粒
Adv Healthc Mater. 2021 Mar;10(5):e2001294. doi: 10.1002/adhm.202001294. Epub 2020 Dec 4.
9
Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release.内源性和外源性刺激响应型药物输送系统用于编程的特定部位释放。
Molecules. 2019 Mar 21;24(6):1117. doi: 10.3390/molecules24061117.
10
'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective.用于器官选择性全身递送的“被动”纳米颗粒:设计、机制和展望。
Chem Soc Rev. 2023 Oct 30;52(21):7579-7601. doi: 10.1039/d2cs00998f.

引用本文的文献

1
Emerging roles of tsRNAs in programmed cell death and disease therapeutics: challenges, opportunities, and future directions.tsRNAs在程序性细胞死亡和疾病治疗中的新作用:挑战、机遇与未来方向
Noncoding RNA Res. 2025 Jul 11;15:65-73. doi: 10.1016/j.ncrna.2025.07.003. eCollection 2025 Dec.
2
Smart Nanoarchitectures for Precision RNA Delivery: Harnessing Endogenous and Exogenous Stimuli in Cancer Treatment.用于精准RNA递送的智能纳米结构:在癌症治疗中利用内源性和外源性刺激
Theranostics. 2025 Jul 2;15(15):7747-7778. doi: 10.7150/thno.112492. eCollection 2025.
3
Recent Advances in mRNA Delivery Systems for Cancer Therapy.

本文引用的文献

1
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome.使用展示RNA配体的外泌体将RNA干扰靶向递送至癌细胞。
Acta Pharm Sin B. 2023 Apr;13(4):1383-1399. doi: 10.1016/j.apsb.2022.11.019. Epub 2022 Nov 17.
2
ROS-Responsive Nanoparticle Delivery of mRNA and Photosensitizer for Combinatorial Cancer Therapy.ROS 响应型纳米颗粒递呈 mRNA 和光敏剂用于联合癌症治疗。
Nano Lett. 2023 May 10;23(9):3661-3668. doi: 10.1021/acs.nanolett.2c03784. Epub 2023 Apr 24.
3
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy.
用于癌症治疗的mRNA递送系统的最新进展
Adv Sci (Weinh). 2025 Aug;12(29):e17571. doi: 10.1002/advs.202417571. Epub 2025 May 20.
4
Nanoparticle-mediated sodium butyrate delivery for repairing hypoxic-ischemic brain injury in premature infants.纳米颗粒介导丁酸钠递送用于修复早产儿缺氧缺血性脑损伤
Mater Today Bio. 2025 Mar 14;32:101665. doi: 10.1016/j.mtbio.2025.101665. eCollection 2025 Jun.
5
GOLPH3 promotes calcium oxalate-induced renal injury and fibrosis through Golgi stress-mediated apoptosis and inflammatory responses.高尔基体磷蛋白3通过高尔基体应激介导的细胞凋亡和炎症反应促进草酸钙诱导的肾损伤和纤维化。
Sci Rep. 2025 Mar 4;15(1):7640. doi: 10.1038/s41598-025-91638-0.
6
Lactylation-Driven HECTD2 Limits the Response of Hepatocellular Carcinoma to Lenvatinib.乳酸化驱动的HECTD2限制肝细胞癌对乐伐替尼的反应。
Adv Sci (Weinh). 2025 Apr;12(15):e2412559. doi: 10.1002/advs.202412559. Epub 2025 Feb 20.
7
A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework.医学及其他领域中使用的纳米载体的系统评价——定义与分类框架
J Nanobiotechnology. 2025 Feb 7;23(1):90. doi: 10.1186/s12951-025-03113-7.
8
Hybrid RNA/DNA Concatemers and Self-Limited Complexes: Structure and Prospects for Therapeutic Applications.杂交RNA/DNA串联体与自限性复合物:结构及治疗应用前景
Molecules. 2024 Dec 13;29(24):5896. doi: 10.3390/molecules29245896.
9
Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery.非编码 RNA 在 2 型糖尿病中的新兴作用:从机制到药物发现。
Biomolecules. 2024 Oct 27;14(11):1364. doi: 10.3390/biom14111364.
10
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications.mRNA 药物在临床前和临床应用中的进展和前景。
Signal Transduct Target Ther. 2024 Nov 14;9(1):322. doi: 10.1038/s41392-024-02002-z.
纳米颗粒介导的系统性mRNA递送以逆转曲妥珠单抗耐药性用于有效的乳腺癌治疗。
Acta Pharm Sin B. 2023 Mar;13(3):955-966. doi: 10.1016/j.apsb.2022.09.021. Epub 2022 Oct 4.
4
Mitochondria-Targeted Gene Silencing Facilitated by Mito-CPDs.由线粒体交联光动力学药物促进的线粒体靶向基因沉默
Chemistry. 2023 May 8;29(26):e202204021. doi: 10.1002/chem.202204021. Epub 2023 Mar 27.
5
Polymer-Based mRNA Delivery Strategies for Advanced Therapies.基于聚合物的 mRNA 递呈策略用于先进疗法。
Adv Healthc Mater. 2023 Jun;12(15):e2202688. doi: 10.1002/adhm.202202688. Epub 2023 Feb 27.
6
Hypoxia, acidification and oxidative stress in cells cultured at large distances from an oxygen source.细胞与氧源距离较大时的缺氧、酸化和氧化应激。
Sci Rep. 2022 Dec 15;12(1):21699. doi: 10.1038/s41598-022-26205-y.
7
Engineering circular RNA for enhanced protein production.工程环状 RNA 以提高蛋白质产量。
Nat Biotechnol. 2023 Feb;41(2):262-272. doi: 10.1038/s41587-022-01393-0. Epub 2022 Jul 18.
8
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.缺氧信号在人类健康和疾病中的作用:治疗学的意义和前景。
Signal Transduct Target Ther. 2022 Jul 7;7(1):218. doi: 10.1038/s41392-022-01080-1.
9
tRNA dysregulation and disease.tRNA 失调与疾病。
Nat Rev Genet. 2022 Nov;23(11):651-664. doi: 10.1038/s41576-022-00501-9. Epub 2022 Jun 9.
10
RNA modifications can affect RNase H1-mediated PS-ASO activity.RNA修饰可影响核糖核酸酶H1介导的PS-ASO活性。
Mol Ther Nucleic Acids. 2022 May 11;28:814-828. doi: 10.1016/j.omtn.2022.05.024. eCollection 2022 Jun 14.